Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with dementia:
- A doctor has confirmed a diagnosis of probable Alzheimer's disease
- The dementia is mild, based on results from standard memory and thinking tests (confirm with trial site for specific scores)
- The person is older than 55 years
- The person is able to follow the study procedures
- The person has vision of at least 20/400 (with glasses or contacts if needed) in at least one eye
- The person has a legally authorised representative who can sign the consent form and attend the study visit with them
For people without dementia (comparison group):
- The person is older than 55 years
- The person is able to follow the study procedures
- The person is able to hold their gaze steady during the eye-imaging procedure
- The person has vision of at least 20/40 (with glasses or contacts if needed) in at least one eye
- The person has no diagnosis of dementia, based on standard memory and thinking tests (confirm with trial site for specific scores)
Who may not be able to join:
- People who have a neurological condition unrelated to Alzheimer's disease that affects the brain or nervous system, such as multiple sclerosis or Parkinson's disease
- People whose eye examination in the past year showed eye diseases that could affect the study results, such as glaucoma, diabetic eye disease, or high blood pressure-related eye damage
- People who have cloudiness in the eye — such as cataracts, corneal scarring, or cloudiness in the gel inside the eye — that could interfere with retinal imaging
- People who have had previous eye surgery, except for straightforward cataract removal with a standard lens implant
- People who are unable to hold their gaze steady during the eye scan, or who are unable to give informed consent
- People whose prescription glasses strength falls outside a certain range, or who have a significant level of astigmatism (confirm with trial site for specific measurements)
- People who have had diabetes for more than 10 years, or whose recent blood sugar control levels were above a certain threshold in the 180 days before the eye scan
- People with uncontrolled high blood pressure above a certain level (confirm with trial site for specific readings)
- People with an irregular heartbeat, or a heart rate outside the range of 50 to 110 beats per minute
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Huang, MD, PhD, Oregon Health and Science University
Phone: 503-494-4351
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Retinal amyloid protein detection
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.